Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.268NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.268NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.268NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.344NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.344NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.344NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.103NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.103NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.103NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.485NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.485NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.485NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.119NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.119NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.119NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.276NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.276NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.276NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.111NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.111NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.111NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.336NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.336NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.336NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.400.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.400.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.400.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.537NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.537NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.537NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.548NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.548NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.548NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.24.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.24.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.24.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.492NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.492NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.492NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.540NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.540NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.540NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.487NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used